Inauguration of the 7‑Tesla MRI at Lille University Hospital: a major step forward for TIPITCH

On 28 April, Lille University Hospital (CHU de Lille), lead institution of the RHU TIPITCH project, inaugurated its 7‑Tesla MRI scanner—an exceptional piece of equipment opening up unprecedented opportunities for clinical research in neuroscience and neurovascular diseases.

This ultra‑high‑resolution imaging technology represents a major strategic asset for the TIPITCH project – Transforming the prognosis of haemorrhagic stroke.

A key lever to better understand haemorrhagic stroke
Within TIPITCH, the 7T MRI will be used to:

🔹 Identify new imaging biomarkers of peri‑haematomal oedema following intracerebral haemorrhage
🔹 Improve the identification of patients at risk of severe disease progression
🔹 Refine predictions of functional outcome, a central challenge for personalised patient care

The ambition: to enhance anticipation and clinical decision‑making through ultra‑high‑precision imaging.

Proven expertise leading the way
This ambitious programme will rely on the excellence of the CHU de Lille teams, under the leadership of:
  • Prof Grégory Kuchcinski
  • Dr Renaud Lopes
Their expertise, combined with the unique capabilities of the 7T MRI, is a decisive asset for the scientific success of the project.

What’s next?

First TIPITCH patient inclusions: before summer 2026

This inauguration fully illustrates the CHU de Lille’s ability to bring together cutting‑edge infrastructure, clinical excellence and translational research, all in the service of patients affected by haemorrhagic stroke.

To learn more about the 7‑Tesla MRI at Lille University Hospital: ARIANES : mise en réseaux des IRM 3 Tesla